Literature DB >> 22183478

Bronchoalveolar lavage pepsin in acute exacerbation of idiopathic pulmonary fibrosis.

J S Lee1, J W Song, P J Wolters, B M Elicker, T E King, D S Kim, H R Collard.   

Abstract

Some patients with idiopathic pulmonary fibrosis experience acute exacerbations in their respiratory status leading to substantial morbidity and mortality. Occult aspiration of gastric contents has been proposed as one possible mechanism leading to these acute exacerbations. We sought to determine whether pepsin, a marker of gastric aspiration, is elevated in bronchoalveolar lavage fluid obtained from patients during acute exacerbation of idiopathic pulmonary fibrosis, compared with that obtained in stable disease. Lavage samples were obtained in a case-control study of well-characterised patients. Acute exacerbation was defined using standard criteria. Levels of lavage pepsin were compared in cases and controls, and were correlated with clinical features and disease course. 24 cases with acute exacerbations and 30 stable controls were identified. There were no significant differences in baseline demographics between the two groups. Pepsin level was an indicator of acute exacerbation status (p=0.04). On average, pepsin appeared higher in patients with acute exacerbations compared with stable controls. This difference was driven by a subgroup of eight patients (33%) with pepsin levels ≥70 ng·mL(-1). Pepsin level was not an independent predictor of survival time. These results suggest occult aspiration may play a role in some cases of acute exacerbation of idiopathic pulmonary fibrosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22183478      PMCID: PMC5529033          DOI: 10.1183/09031936.00050911

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  25 in total

Review 1.  American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS).

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2000-02       Impact factor: 21.405

2.  Pepsin like activity in bronchoalveolar lavage fluid is suggestive of gastric aspiration in lung allografts.

Authors:  C Ward; I A Forrest; I A Brownlee; G E Johnson; D M Murphy; J P Pearson; J H Dark; P A Corris
Journal:  Thorax       Date:  2005-07-29       Impact factor: 9.139

3.  Incidence and prevalence of idiopathic pulmonary fibrosis.

Authors:  Ganesh Raghu; Derek Weycker; John Edelsberg; Williamson Z Bradford; Gerry Oster
Journal:  Am J Respir Crit Care Med       Date:  2006-06-29       Impact factor: 21.405

4.  Pepsin as a marker for pulmonary aspiration.

Authors:  Norma A Metheny; Yie-Hwa Chang; Jing Song Ye; Sharon J Edwards; Julie Defer; Thomas E Dahms; Barbara J Stewart; Kathleen S Stone; Ray E Clouse
Journal:  Am J Crit Care       Date:  2002-03       Impact factor: 2.228

5.  Gastroesophageal reflux and pulmonary aspiration: incidence, functional abnormality, and results of surgical therapy.

Authors:  C A Pellegrini; T R DeMeester; L F Johnson; D B Skinner
Journal:  Surgery       Date:  1979-07       Impact factor: 3.982

6.  A new pepsin assay to detect pulmonary aspiration of gastric contents among newly intubated patients.

Authors:  Jacob W Ufberg; Joseph S Bushra; Dilipkumar Patel; Elliot Wong; David J Karras; Friedrich Kueppers
Journal:  Am J Emerg Med       Date:  2004-11       Impact factor: 2.469

7.  Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model.

Authors:  T E King; J A Tooze; M I Schwarz; K R Brown; R M Cherniack
Journal:  Am J Respir Crit Care Med       Date:  2001-10-01       Impact factor: 21.405

8.  Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis.

Authors:  R W Tobin; C E Pope; C A Pellegrini; M J Emond; J Sillery; G Raghu
Journal:  Am J Respir Crit Care Med       Date:  1998-12       Impact factor: 21.405

9.  Bronchoalveolar pepsin, bile acids, oxidation, and inflammation in children with gastroesophageal reflux disease.

Authors:  Vitaliy Starosta; Richard Kitz; Dominik Hartl; Veronica Marcos; Dietrich Reinhardt; Matthias Griese
Journal:  Chest       Date:  2007-10-09       Impact factor: 9.410

10.  Pepsin in bronchoalveolar lavage fluid: a specific and sensitive method of diagnosing gastro-oesophageal reflux-related pulmonary aspiration.

Authors:  Stephen Farrell; Cyril McMaster; David Gibson; Michael D Shields; William A McCallion
Journal:  J Pediatr Surg       Date:  2006-02       Impact factor: 2.545

View more
  54 in total

1.  Eosinophilic pneumonia associated with pirfenidone therapy.

Authors:  Diana C Gomez; Borna Mehrad
Journal:  Eur Respir J       Date:  2016-07-07       Impact factor: 16.671

2.  Acute exacerbation of idiopathic pulmonary fibrosis associated with air pollution exposure.

Authors:  Kerri A Johannson; Eric Vittinghoff; Kiyoung Lee; John R Balmes; Wonjun Ji; Gilaad G Kaplan; Dong Soon Kim; Harold R Collard
Journal:  Eur Respir J       Date:  2013-10-31       Impact factor: 16.671

3.  Update in Interstitial Lung Disease 2016.

Authors:  Athol U Wells; Toby M Maher
Journal:  Am J Respir Crit Care Med       Date:  2017-07-15       Impact factor: 21.405

4.  Identification of Helicobacter pylori VacA in human lung and its effects on lung cells.

Authors:  Shota Nakashima; Tomoyuki Kakugawa; Hirokazu Yura; Masaomi Tomonaga; Tatsuhiko Harada; Atsuko Hara; Shintaro Hara; Masayuki Nakano; Eiki Yamasaki; Noriho Sakamoto; Yuji Ishimatsu; Hajime Isomoto; Bernadette R Gochuico; Anthony F Suffredini; Hiroshi Mukae; Hisao Kurazono; Toshiya Hirayama; Joel Moss; Shigeru Kohno
Journal:  Biochem Biophys Res Commun       Date:  2015-03-25       Impact factor: 3.575

5.  Acute Exacerbation of Idiopathic Pulmonary Fibrosis: A Proposal.

Authors:  Kerri Johannson; Harold R Collard
Journal:  Curr Respir Care Rep       Date:  2013-12

Review 6.  Contributions of alveolar epithelial cell quality control to pulmonary fibrosis.

Authors:  Jeremy Katzen; Michael F Beers
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

Review 7.  Pathogenesis of idiopathic pulmonary fibrosis.

Authors:  Paul J Wolters; Harold R Collard; Kirk D Jones
Journal:  Annu Rev Pathol       Date:  2013-09-13       Impact factor: 23.472

Review 8.  New therapeutic targets in idiopathic pulmonary fibrosis. Aiming to rein in runaway wound-healing responses.

Authors:  Neil Ahluwalia; Barry S Shea; Andrew M Tager
Journal:  Am J Respir Crit Care Med       Date:  2014-10-15       Impact factor: 21.405

Review 9.  The pulmonary side of reflux disease: from heartburn to lung fibrosis.

Authors:  Marco E Allaix; P Marco Fisichella; Imre Noth; Bernardino M Mendez; Marco G Patti
Journal:  J Gastrointest Surg       Date:  2013-04-25       Impact factor: 3.452

10.  Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials.

Authors:  Joyce S Lee; Harold R Collard; Kevin J Anstrom; Fernando J Martinez; Imre Noth; Rhonda S Roberts; Eric Yow; Ganesh Raghu
Journal:  Lancet Respir Med       Date:  2013-06-14       Impact factor: 30.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.